Needham upgrades Cooper Companies stock rating on growth outlook

Needham upgraded Cooper Companies (COO) to Buy with a $94 price target, citing an attractive entry point due to a valuation dislocation and strong contact lens market growth. This upgrade contrasts with recent mixed analyst actions, including downgrades from JPMorgan and Piper Sandler due to revised growth expectations, despite Cooper's Q2 2025 EPS of $0.96 and revenue of $1,002 million exceeding estimates.

Analysis

Needham has upgraded Cooper Companies (COO) to Buy with a $94.00 price target, identifying a valuation dislocation as an attractive entry point, given the stock trades at $69.74, near its 52-week low of $65.00. This positive outlook is supported by a "GOOD" Financial Health Score from InvestingPro, upward earnings revisions by 11 analysts, and InvestingPro analysis suggesting the stock is undervalued. The contact lens market is reportedly tracking at the mid- to upper-end of Cooper’s assumed 4-6% growth range, with Cooper expected to outperform this market by approximately 150 basis points, leveraging its $3.99 billion revenue and 67.2% gross margin. The company notes premium lenses are outperforming lower-priced options, and it aims to grow its daily disposable lens market share from 21% to the mid- to high-20% range. Management remains committed to low-double digit constant currency operating income growth, potentially achievable by fiscal year 2026 despite tariff impacts, with Needham forecasting reported EPS growth to exceed high-single digit consensus estimates for FY26 due to favorable currency, debt reduction, and share repurchases. COO currently trades at 15.6 times Needham’s 2026 earnings estimate, a 19% discount to large-cap peers and a 29% discount to its ten-year average forward P/E. However, this upgrade contrasts with a mixed broader analyst sentiment following Cooper's Q2 2025 results, where EPS of $0.96 and revenue of $1,002 million surpassed expectations, but the company revised its revenue growth outlook downwards. Piper Sandler maintained an Overweight rating but lowered its price target to $105, JPMorgan downgraded to Neutral with a $76 target due to concerns over decreased organic sales forecasts, while Stifel reiterated a Buy. These cautious views stem from revised growth expectations in key markets and increased R&D expenses.

Key Decisions for Investors

• Investors should weigh Needham's bullish valuation-driven upgrade and Cooper's fundamental strengths, such as market outperformance and margin resilience, against the company's recently revised cautious revenue guidance and mixed analyst sentiment.
• Consider the current trading level near the 52-week low as a potential entry point if aligning with the undervaluation thesis, but remain cognizant of risks tied to revised growth forecasts and increased R&D expenditure.
• Monitor key performance indicators including progress in gaining daily disposable lens market share, the ability to achieve targeted operating income growth despite tariffs, and management's execution against the backdrop of a more conservative near-term outlook.